Skip to content
Lower risk Medical device recall · FDA · Published February 5, 2026

Remel Campy CVA Medium 100/PK recall: Low Campylobacter recovery risk

Remel recalls Campy CVA Medium 100/PK (lot R01272) due to low Campylobacter Jejuni recovery in testing. This may affect lab use. No remedy specified.

🇺🇸 FDA recall #Z-1474-2026Medical deviceRemel ›
Take action

Contact the company

Recalling firmRemel, Inc12076 Santa Fe Trail Dr · Lenexa, KS 66215-3519
✎ GovInfoNow plain-language explainer

Remel is recalling Campy CVA Medium 100/PK (lot R01272) because lab tests showed low recovery of Campylobacter Jejuni. This could mean the medium isn't reliably detecting the bacteria, which is important for lab work. Read more at govinfonow.com/recall/50049-remel-campy-cva-medium-100-pk-recall-low-campylobacter-recovery.

Source Summary by GovInfoNow · govinfonow.com/recall/50049-remel-campy-cva-medium-100-pk-recall-low-campylobacter-recovery · Updated August 10, 2026 · FDA enforcement record: FDA #Z-1474-2026

Cite this page

“Remel Campy CVA Medium 100/PK recall: Low Campylobacter recovery risk.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/50049-remel-campy-cva-medium-100-pk-recall-low-campylobacter-recovery. Based on FDA recall #Z-1474-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1474-2026%22&limit=1).

The FDA announced on Feb. 5, 2026, that Remel, Inc. voluntarily recalled Campy CVA Medium 100/PK due to customer reports of low to no recovery of Campylobacter Jejuni ATCC 33291. The agency issued recall number Z-1474-2026 for the Class II device.

How to tell if you have it

  • Brand: Remel
  • Product: Campy CVA Medium 100/PK
  • Lot code: R01272
  • Lot number: 339135
  • Expiration date: January 12, 2026
  • UDI-DI: 848838001055

The hazard

Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on the identified lot of medium. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Remel, Inc. has 22 other recalls on record since Nov. 2, 2017. Other recent recalls of similar products include Remel GC Agar Base Recall (June 3, 2026), Remel Yeastone Broth Recall (March 24, 2026), and Remel Lab Culture Media Recall (Nov. 12, 2025). Other recent recalls of similar products include Microbiologics LYFO DISK recall (Dec. 2, 2025) and Microbiologics KWIK-STIK 6-Pack Recall (Dec. 2, 2025).

How to tell if you have this one

Check for the lot number R01272 on the packaging. The product expires January 12, 2026. This specific lot was identified in testing.

  • Brand
    Remel
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Lot

    Look for the lot number R01272 on the packaging to confirm if your product is affected.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 7 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: named in the noticeOHPennsylvania: nationwidePANew Jersey: named in the noticeNJConnecticut: nationwideCTCalifornia: nationwideCAUtah: nationwideUTColorado: named in the noticeCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: nationwideTXFlorida: nationwideFL

FDA distribution: “US Nationwide distribution in the states of AZ, CO, IL, NJ, OH, TN, WA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Arizona, Colorado, Illinois, New Jersey, Ohio, Tennessee, Washington.

Recall timeline

FDA published this recall 27 days after the firm started it.

1. Firm started the recall: Feb 5, 202612. FDA classified it Class II: Feb 26, 202623. Published in FDA’s Enforcement Report: Mar 4, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1474-2026 (February 5, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1474-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA